these people have been around for awhile and have worked with gdnf - obviously still believe in it. Gill, from the UK, was an investigator in the phase II halt, didn't agree with the halt but stayed out of it and focused on better delivery.

http://www.genengnews.com/news/bnite...?name=72730472

try this one: http://www.pdonlineresearch.org/news...apy-parkinsons

Jan 12 2010, 3:00 AM EST

MedGenesis Announces Agreements With Amgen and Biovail

MARKETWIRE

Jan 12, 2010VICTORIA, BRITISH COLUMBIAMARKETWIRE

MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. (NASDAQ: AMGN) ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries....

MedGenesis has also granted Biovail a license to its Convection Enhanced Delivery (CED) platform for use with GDNF in CNS indications. MedGenesis and Biovail will initially focus on the development of GDNF for Parkinson's disease, a progressive and debilitating neurological disease affecting close to 5 million patients worldwide.


paula